Rossari Biotech Ltd (ROSB)

Currency in INR
503.00
+5.60(+1.13%)
Closed·

Rossari Biotech (ROSB) Stock Forecast & Price Target

Advanced Equity Forecast
Overall Consensus
Strong Buy
3 Buy
1 Hold
0 Sell
Data based on a poll of the past 3 months

Analysts 12-Month Price Target

Average 610.50
(+21.37% Upside)

Past 24 Months

12-Month Forecast

Analyst Ratings

Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
ICICI Securities
Buy605.00+20.28%570.00MaintainJul 21, 2026
ICICI Securities
Buy570.00+13.32%660.00MaintainApr 29, 2026
ICICI Securities
Buy760.00+51.09%-MaintainOct 20, 2025

Fair Value

Average
Upside
Uncertainty
Spread
Market Range
52 weeks
₹375
₹690
Analyst Targets
4 analysts
₹570
₹637
Fair Value
15 models

FAQ

Is ROSB a Buy, Sell, or Hold?

The consensus rating for Rossari Biotech is "Strong Buy", based on insights from 4 analysts. 3 analysts recommend buying the stock, 0 suggest selling, and 1 recommend holding.

What Is the Price Target for Rossari Biotech (ROSB) According to Analysts?

According to projections from 4 analysts, the average 12-month price target for Rossari Biotech is 610.50 INR, with a high estimate of 637 INR and a low estimate of 570 INR.

What Is ROSB’s Potential Upside or Downside, Based on the Analysts’ Average Price Target?

Rossari Biotech has a potential Upside of +21.37%, based on analysts’ average price target.

How Has Rossari Biotech Stock Performed Over the Past 52 Weeks?

The Rossari Biotech 52-week range spans from 375.00 to 690.30.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.